Investor FAQs

• When did Astex Pharmaceuticals, Inc. go public?

  +/-

  Astex Pharmaceuticals' former company name was SuperGen (formerly NASDAQ: SUPG). SuperGen became a public company in March 1996 at $6/unit. Each unit consisted of one share of common and one warrant.

• What are Astex Pharmaceuticals' fiscal quarter and year-end dates?

  +/-

  Astex Pharmaceuticals operates on a fiscal year ending December 31st. Our quarterly reporting periods end on March 31st, June 30th, September 30th, and December 31st.

• What are Astex Pharmaceuticals' stock symbol and CUSIP number?

  +/-

  The Astex Pharmaceuticals stock symbol is ASTX and is traded on the NASDAQ. The CUSIP number is 04624B 103.

• How do I track down lost certificates or change my address?

  +/-

  Contact our transfer agent, Computershare, at (877) 255-1887.

• Does Astex Pharmaceuticals pay a dividend?

  +/-

  Not at this time.

• Does Astex Pharmaceuticals offer a direct stock purchase plan or a dividend reimbursement plan?

  +/-

  Not at this time.

• Do you have another question that hasn't been answered?

  +/-

  Please submit your question using the form below. * Required fields

  
  

  Name *
  Email *
  Subject *
  Comments *
  Type in number *
  	This helps Astex Pharmaceuticals prevent automated submissions.

Analyst Coverage

Astex Pharmaceuticals is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Astex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Astex Pharmaceuticals or its management. Astex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Chart

3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

• Stockholder Briefcase
• Investor Kit
• Email Alerts
• Download library
• Snapshot
• RSS News Feeds


• Print Page
• Email Page
• Share This

Share this on:
Delicious
Digg
Facebook
LinkedIn
Twitter
What is this?